Explore Stanford technologies available for licensing:

Stanford researchers have developed aldehyde-containing hydrogels that release bacteriophage, with or without antibiotics, over a controlled and sustained manner to treat infections including orthopedic joint infections, wound infections, ear infections (chronic suppurative ot

Stanford researchers have invented a novel nanobody-based platform for specific activation of bone and cartilage regeneration.

Stanford researchers have developed novel viral markers from tomato brown rugose fruit virus (ToBRFV). The marker is a good indicator of 1) environmental fecal contamination, 2) fecal load in wastewater, and 3) internal control for viral RNA extraction from stool.

Cell culture is a central technique used for a plethora of research applications including in the modeling of complex diseases, creating transgenic animals, gene therapy, cell therapy, regenerating lost tissue, and organ biogenesis.

Stanford researchers are changing the way we approach neuropsychiatric care; they've delved into the complex world of brain signals and developed an analysis that distinguishes cravings from basic needs like hunger and sleep, offering a whole new way to fine-tune treatments fo

Stanford researchers in the Khosla lab have invented a new class of "molecular glues" that couple the enzymatic activity of a cell-surface enzyme, transglutaminase 2 (TG2), with the ability of the LDL receptor-related protein 1 (LRP-1) to promote receptor-mediated endocytosis

Researchers at Stanford have synthesized a potential novel class of pain relief drugs.

Researchers at Stanford have developed a new method of drug screening using lanthanide-encoded beads.

Researchers at Stanford have invented a method using directed evolution for predicting antibody improved antibody variants.

Stanford researchers in the Wu Lab have developed hypoallergenic and immunogenic induced pluripotent stem cells that could be used as a cancer treatment or prophylactic.

Stanford researchers have created a novel wearable device and system to assess fatigue on the user based on electrical activity associated with an eye blink of the subject.

We present a revolutionary advancement in ferroelectric materials that is set to redefine the landscape of embedded memories and semiconductor technologies.

Researchers at Stanford have developed a potent, insulin-based, insulin receptor antagonist that could be used as a hyperinsulinism therapeutic.

This invention is an innovative breakthrough in cancer radiotherapy, offering a cutting-edge solution to address the challenges of radio-resistant and immunosuppressive tumors.

Stanford researchers have developed a single-cell technology for a targeted high-throughput multiomic readout of RNA and gDNA.